Clinical Trial Update: Clinical Efficacy in Relief of Dyspnea by HVNI: Evaluation of New Device Equivalence [NA]

View source ↗

Summary

A terminated clinical trial evaluating new device equivalence for relief of dyspnea using high-velocity nasal insufflation (HVNI); results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea
• Hypercapnia
• Respiratory Insufficiency

Drugs mentioned

• HVNI device (Vapotherm)

Snippet

Sponsor: Vapotherm, Inc. | Conditions: Dyspnea, Hypercapnia | NA | Status: TERMINATED | Results posted: 2024-03-20